Tirzepatide: beside a new treatment under test
24 studies: a new drug, cell therapy or vaccine is what the study tests. Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesRecruitingNCT07881458Phase 3How we knowReport a problem
- A Study of EloraTZP in Adult Participants With Obesity Without Type 2 DiabetesNot yet recruitingNCT07881432Phase 3How we knowReport a problem
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide MedicationRecruitingNCT07868354Phase 1How we knowReport a problem
- A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese ParticipantsNot yet recruitingNCT07671391Phase 2How we knowReport a problem
- Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor AgonistsRecruitingNCT07619989Not applicableHow we knowReport a problem
- A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLDRecruitingNCT07527910Phase 2How we knowReport a problem
- Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and ObesityRecruitingNCT07245771Phase 1/2How we knowReport a problem
- A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes MellitusRecruitingNCT06937203Phase 1/2How we knowReport a problem
- A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or ObesityRecruitingNCT06842186Phase 1/2How we knowReport a problem
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or ObeseNot yet recruitingNCT06732245Phase 2How we knowReport a problem
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruitingNCT06143956Phase 2How we knowReport a problem
- A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related ComorbidityActive, not recruitingNCT06965413Phase 2How we knowReport a problem
- A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or ObesityCompletedNCT06916065Phase 1How we knowReport a problem
- A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy ParticipantsCompletedNCT06890611Phase 1How we knowReport a problem
- A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes MellitusActive, not recruitingNCT06700538Phase 1/2How we knowReport a problem
- A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 DiabetesCompletedNCT06603571Phase 2How we knowReport a problem
- Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and OverTerminatedNCT06515418Phase 2How we knowReport a problem
- Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on TirzepatideActive, not recruitingNCT06484114Not applicableHow we knowReport a problem
- Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or ObeseCompletedNCT06445075Phase 2How we knowReport a problem
- A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityCompletedNCT06373146Phase 2How we knowReport a problem
- A Study of LY3841136 in Overweight and Obese ParticipantsCompletedNCT06345066Phase 1How we knowReport a problem
- A Study of LY3841136 in Japanese Participants With Obesity or OverweightCompletedNCT06297616Phase 1How we knowReport a problem
- Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without DiabetesActive, not recruitingNCT05822544Phase 1How we knowReport a problem
- A Study of LY3457263 in Obese ParticipantsCompletedNCT05582096Phase 1How we knowReport a problem